Skip to main content

Research News

academics

 

Clinical research courses

  • Researcher Identifies PICH Protein as Key Player in Preventing Chromosome Breakage Linked to Cancer

    Researchers at The University of Hong Kong have made an exciting discovery about how human cells protect DNA during cell division, offering new insights into combating diseases such as cancer. Led by Professor Gary Ying Wai CHAN from the School of Biological Sciences, Faculty of Science, and Professor Ken Hoi Tang MA from the Department of Pathology, LKS Faculty of Medicine, the research uncovers the vital role of a protein called PICH in preventing genetic errors that can lead to diseases such as cancer. Their findings were recently published in the journal Nucleic Acids Research.
  • A major advance in biology combines DNA and RNA and could revolutionise cancer treatments
    Our genes contain all the instructions our body needs to function, but their expression must be finely regulated to guarantee that each cell performs its role optimally. This is where DNA and RNA epigenetics comes in : a series of mechanisms that act as markers on genes, to control their activity without modifying the DNA or RNA sequence itself.
  • New study paves way for immunotherapies tailored for childhood cancers

    Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s immune systems react to different kinds of cancer depending on their age. The study, which is published in the journal Cell, reveals significant differences between the immune response of children and adults, and has the potential to lead to new tailored treatments for children with cancer.

  • Drugs for Rare Diseases - New Brunswick Agreement

    The Governments of Canada and the province of New Brunswick signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over 32 million USD over three years to improve access to new drugs for rare diseases for New Brunswick residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.

  • US exits WHO, Trump signs executive order

    US withdraws from WHO after mishandling of the COVID-19 pandemic from WHO and signs executive order.

    The United States noticed its withdrawal from the World Health Organization (WHO) in 2020 due to the organization’s mishandling of the COVID-19 pandemic that arose out of Wuhan, China, and other global health crises, its failure to adopt urgently needed reforms, and its inability to demonstrate independence from the inappropriate political influence of WHO member states.

  • Florescent Probes Illuminate Cholesterol and Alzheimer’s Research
    The search for answers to Alzheimers disease and other neurodegenerative disorders remains one of the most pressing goals in brain research. Maciej J. Stawikowski, Ph.D., an assistant professor of chemistry and biochemistry at Florida Atlantic Universitys Charles E. Schmidt College of Science, believes the key may lie in understanding how cholesterol and other lipids move through cells and affect their communication.
  • Brain changes in Huntington’s disease decades before diagnosis will guide future prevention trials

    Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately twenty years before a clinical motor diagnosis in people with Huntington’s disease, finds a new study led by UCL researchers.

  • Detecting disease with only a single molecule

    UC Riverside scientists have developed a nanopore-based tool that could help diagnose illnesses much faster and with greater precision than current tests allow, by capturing signals from individual molecules.

  • HKUMed confirms clozapine safety with first big-data evidence on rare blood cancer cases
    An inter-departmental research team at the LKS Faculty of Medicine of the University of Hong Kong has conducted the world’s first analytic real-world cohort study on the association of clozapine, a highly efficacious antipsychotic drug, with the incidence of blood cancer.
  • New scan method unveils lung function secrets

    The scan method has enabled the team, led by researchers at Newcastle University, UK, to see how air moves in and out of the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary disease (COPD), and patients who have received a lung transplant.

Subscribe to Research News